ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Operating cash flow 2018–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.6MFY2025 · since FY2018: -$14.1M → -$5.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.6M | +95.0% |
| FY2024 | -$112.2M | +54.6% |
| FY2023 | -$247.1M | +4.1% |
| FY2022 | -$257.7M | -47.6% |
| FY2021 | -$174.6M | -54.5% |
| FY2020 | -$113.0M | -163.9% |
| FY2019 | -$42.8M | -204.1% |
| FY2018 | -$14.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice